<h1>GPT Healthcare Ltd Announces Board Meeting for Q1 Financial Results Review</h1>
GPT Healthcare Ltd has scheduled a meeting of its Board of Directors to consider and approve the Unaudited Financial Results, along with the Limited Review Report of the Statutory Auditor, for the first quarter ended June 30, 2026.
The Board meeting is set to be held on Monday, August 3, 2026. The purpose of the gathering includes reviewing and approving the financial outcomes as reported by the company's statutory auditor for the specified period.
In addition to the board event, GPT Healthcare Ltd confirmed that the trading window for its securities will remain closed until August 5, 2026. This closure continues in adherence to the company’s Code of Conduct for Prevention of Insider Trading, which typically lasts until 48 hours after un-published price sensitive information is submitted to the Stock Exchanges.
GPTHEALTH Stock Price Movement
GPT Healthcare Limited shares gained 2.07% on Friday, settling at ₹159.64 following robust trading activity. The stock closed with a total traded volume of 519,007 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.